228. Bronchiolitis obliterans Clinical trials / Disease details


Clinical trials : 96 Drugs : 125 - (DrugBank : 34) / Drug target genes : 33 - Drug target pathways : 155

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01650545
(ClinicalTrials.gov)
July 201227/6/2012Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant RecipientsA Pilot Study to Demonstrate Efficacy and Safety of Aerosol Liposomal Cyclosporine (L-CsA) in the Treatment of Bronchiolitis Obliterans Syndrome After Lung TransplantationDisorder Related to Lung Transplantation;Bronchiolitis Obliterans;Decreased Immunologic Activity;Chronic Rejection of Lung TransplantDrug: Liposomal aerosol cyclosporine;Other: standard immune suppression, oralUniversity of Maryland, College ParkNULLCompleted18 YearsN/AAll21Phase 1/Phase 2United States